Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.
作者信息
Frange Pierre, Leruez-Ville Marianne
机构信息
Laboratoire de Microbiologie clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants malades, Paris, France
EHU 7327, Institut Imagine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
出版信息
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00178-19. Print 2019 May.
Abstract
摘要
相似文献
1
Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.在推荐广泛使用来特莫韦作为巨细胞病毒疾病的挽救疗法之前需要谨慎。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00178-19. Print 2019 May.
2
Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases".对弗朗热和勒吕埃 - 维勒的回复：“在推荐广泛使用来特莫韦作为巨细胞病毒疾病的挽救疗法之前需谨慎” 。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00453-19. Print 2019 May.
3
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.来特莫韦作为耐药巨细胞病毒视网膜炎的挽救治疗的应用。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02337-18. Print 2019 Mar.
4
Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantation.来特莫韦预防造血干细胞移植后巨细胞病毒的药代动力学药物评价。
Expert Opin Drug Metab Toxicol. 2018 Dec;14(12):1197-1207. doi: 10.1080/17425255.2018.1550485. Epub 2018 Dec 4.
5
New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by Exposure to Letermovir and Ganciclovir.人巨细胞病毒 UL56 基因中雷帕霉素和更昔洛韦耐药新位点的揭示。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00922-18. Print 2018 Sep.
6
A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance.人巨细胞病毒末端酶复合物的第三个组成部分参与了乐韦莫及耐药性。
Antiviral Res. 2017 Dec;148:1-4. doi: 10.1016/j.antiviral.2017.10.019. Epub 2017 Oct 28.
7
Letermovir for the management of cytomegalovirus infection.来特莫韦用于巨细胞病毒感染的管理。
Expert Opin Investig Drugs. 2017 Feb;26(2):235-241. doi: 10.1080/13543784.2017.1274733. Epub 2016 Dec 28.
8
Letermovir Resistance in Hematopoietic Stem Cell Transplant Recipients: The Risks Associated with Cytomegalovirus Prophylaxis.造血干细胞移植受者中莱特莫韦的耐药性：与巨细胞病毒预防相关的风险
J Infect Dis. 2020 Mar 16;221(7):1036-1038. doi: 10.1093/infdis/jiz578.
9
[Pharmacological and clinical effects of letermovir (Prevymis), a novel anti-human cytomegalovirus prophylactic drug].新型抗人巨细胞病毒预防药物来特莫韦（Prevymis）的药理及临床效果
Nihon Yakurigaku Zasshi. 2019;153(4):192-198. doi: 10.1254/fpj.153.192.
10
In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.来特莫韦（AIC246，MK-8228）与已获批的抗人巨细胞病毒（HCMV）和抗HIV化合物在体外进行药物联合研究，以抑制HCMV和HIV复制。
Antimicrob Agents Chemother. 2015;59(6):3140-8. doi: 10.1128/AAC.00114-15. Epub 2015 Mar 16.
本文引用的文献
1
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.来特莫韦作为耐药巨细胞病毒视网膜炎的挽救治疗的应用。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02337-18. Print 2019 Mar.
2
Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.接受来特莫韦预防治疗的造血干细胞移植受者发生突破性巨细胞病毒肺炎。
Bone Marrow Transplant. 2019 Jun;54(6):911-912. doi: 10.1038/s41409-018-0389-9. Epub 2018 Nov 6.
3
Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis.玻璃体内注射更昔洛韦单药治疗与联合膦甲酸钠作为巨细胞病毒性视网膜炎初始治疗的比较。
Int J Ophthalmol. 2018 Oct 18;11(10):1638-1642. doi: 10.18240/ijo.2018.10.10. eCollection 2018.
4
Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection.拉替拉韦耐药导致肺移植受者更昔洛韦耐药巨细胞病毒感染
Am J Transplant. 2018 Dec;18(12):3060-3064. doi: 10.1111/ajt.15135. Epub 2018 Oct 29.
5
Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir.对位于开放阅读框UL56一个独特区域的两种自然发生的人巨细胞病毒序列多态性进行表型特征分析，该区域已知与体外对来特莫韦的耐药性有关。
Antiviral Res. 2015 Apr;116:48-50. doi: 10.1016/j.antiviral.2015.01.006. Epub 2015 Jan 28.
6
Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism.人巨细胞病毒（CMV）对目前已获批抗病毒药物的敏感性不会影响CMV末端酶复合物的多态性。
Antiviral Res. 2014 Nov;111:8-12. doi: 10.1016/j.antiviral.2014.08.014. Epub 2014 Sep 4.
7
Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure.体外筛选使用乐韦替尼（AIC246）后选择的人巨细胞病毒突变体的基因和表型特征。
Antimicrob Agents Chemother. 2014;58(1):610-3. doi: 10.1128/AAC.01794-13. Epub 2013 Nov 4.
8
Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T cell-depleted haploidentical peripheral blood stem cell transplant recipient.T 细胞耗竭的单倍体相合外周血造血干细胞移植受者发生伴抗病毒耐药的巨细胞病毒分隔的巨细胞病毒性脑室脑炎。
Diagn Microbiol Infect Dis. 2012 Nov;74(3):307-10. doi: 10.1016/j.diagmicrobio.2012.07.006. Epub 2012 Aug 24.
9
Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.在一名对血液中更昔洛韦耐药但眼部对更昔洛韦敏感的患者中，更昔洛韦植入物成功治疗巨细胞病毒性视网膜炎。
Eye (Lond). 2012 May;26(5):759-60. doi: 10.1038/eye.2012.17. Epub 2012 Feb 10.
10
Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.一名患有常染色体隐性重症联合免疫缺陷患者中致命性耐多药巨细胞病毒感染的出现与分区化
J Pediatr Hematol Oncol. 2004 Sep;26(9):601-5. doi: 10.1097/01.mph.0000135283.77668.6a.
Zotero 插件